504 related articles for article (PubMed ID: 27031847)
1. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.
Rajão DS; Chen H; Perez DR; Sandbulte MR; Gauger PC; Loving CL; Shanks GD; Vincent A
J Gen Virol; 2016 Jul; 97(7):1489-1499. PubMed ID: 27031847
[TBL] [Abstract][Full Text] [Related]
2. Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.
Souza CK; Rajão DS; Loving CL; Gauger PC; Pérez DR; Vincent AL
Clin Vaccine Immunol; 2016 Jun; 23(6):470-482. PubMed ID: 27030585
[TBL] [Abstract][Full Text] [Related]
3. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL
Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.
Gauger PC; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA; Vincent AL
Viral Immunol; 2013 Oct; 26(5):314-21. PubMed ID: 24033080
[TBL] [Abstract][Full Text] [Related]
5. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs.
Kimble JB; Wymore Brand M; Kaplan BS; Gauger P; Coyle EM; Chilcote K; Khurana S; Vincent AL
J Virol; 2022 Mar; 96(5):e0172521. PubMed ID: 34985999
[TBL] [Abstract][Full Text] [Related]
8. Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs.
Rajão DS; Loving CL; Gauger PC; Kitikoon P; Vincent AL
Vaccine; 2014 Sep; 32(40):5170-6. PubMed ID: 25077416
[TBL] [Abstract][Full Text] [Related]
9. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL
Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
[TBL] [Abstract][Full Text] [Related]
11. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
12. Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease.
Wymore Brand M; Anderson TK; Kitikoon P; Brian Kimble J; Otis N; Gauger PC; Souza CK; Kaplan B; Mogler M; Strait E; Vincent Baker AL
Vaccine; 2022 Sep; 40(38):5569-5578. PubMed ID: 35987871
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.
Gauger PC; Vincent AL; Loving CL; Henningson JN; Lager KM; Janke BH; Kehrli ME; Roth JA
Vet Pathol; 2012 Nov; 49(6):900-12. PubMed ID: 22461226
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model.
Rosu ME; Kok A; Bestebroer TM; de Meulder D; Verveer EP; Pronk MR; Dekker LJM; Luider TM; Richard M; van den Brand JMA; Fouchier RAM; Herfst S
J Virol; 2022 Mar; 96(6):e0195921. PubMed ID: 35107371
[TBL] [Abstract][Full Text] [Related]
16. Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.
Kitikoon P; Knetter SM; Mogler MA; Morgan CL; Hoehn A; Puttamreddy S; Strait EL; Segers RPAM
Vaccine; 2023 Nov; 41(47):6941-6951. PubMed ID: 37884412
[TBL] [Abstract][Full Text] [Related]
17. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
18. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
19. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
[TBL] [Abstract][Full Text] [Related]
20. Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.
Kitikoon P; Gauger PC; Anderson TK; Culhane MR; Swenson S; Loving CL; Perez DR; Vincent AL
Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):32-41. PubMed ID: 24224818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
